Is the effort to treat experiments in genetics just like clinical trials hurting our ability to use the new technology coming from companies like Illumina, Life Technologies, and Complete Genomics?
The biotechs should, however, get renewed attention as various important biotech industry groups that attract thousands of healthcare investors and professionals start holding their annual conventions and meetings where biotech and life science companies offer their outlook for the comingnew year and present updates on their new products and technologies.
Other skeletons from the Menem years are coming back to life: the United States has turned over to Argentine congressional investigators documents which may reveal new details of money-laundering and corruption.